Predict your next investment

Saccadous company logo
SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
saccadous.com

See what CB Insights has to offer

Stage

Seed | Alive

Total Raised

$20K

Last Raised

$20K | 8 yrs ago

About Saccadous

Saccadous provides a non-invasive eye-tracking solution for diagnosing, tracking and advancing the treatment of neurological diseases and Traumatic Brain Injury (TBI). This is done through the capture and analysis of involuntary eye-movements, know as microsaccades. The company's software driven solution simplifies and mobilizes the eye-tracking while leveraging a cloud-based platform for the analysis, reporting and predictive analytics.

Saccadous Headquarter Location

1475 N. Scottsdale Road Suite 200

Scottsdale, Arizona, 85257,

United States

480-433-9735

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Saccadous

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Saccadous is included in 3 Expert Collections, including Eye Health.

E

Eye Health

711 items

N

Neuroscience

2,144 items

Companies developing products that monitor, analyze, protect, or otherwise influence the structure/function of the nervous system.

H

Health Monitoring & Diagnostics

2,701 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.